Diabetes Mellitus, Type 2: all 9,590 studies

Page 29 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.

• Obstructive Sleep Apnea (OSA), Sleepiness, and Activity in Diabetes ManagementCompletedNCT00801892Phase 3Results posted
• Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background InclusiveCompletedNCT00800683Phase 3Results posted
• A Dose-Finding Study of RO4998452 in Patients With Diabetes MellitusCompletedNCT00800176Phase 2Results posted
• Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage IICompletedNCT00799643Phase 2/3Results posted
• Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart FailureTerminatedNCT00799435Phase 4Results posted
• Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial DesignCompletedNCT00798161Phase 3Results posted
• Impact of Mulberry Leaf on Type 2 DiabetesCompletedNCT00795704Phase 2/3Results posted
• Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin TreatmentCompletedNCT00795600Phase 4Results posted
• A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)CompletedNCT00792935Phase 2Results posted
• MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)CompletedNCT00791661Phase 1Results posted
• Effects of LY2189265 on Glycemic Control in Participants With Type 2 DiabetesCompletedNCT00791479Phase 2Results posted
• Study for Pre-Surgical Weight Loss in Type II Diabetes PatientsCompletedNCT00791128Phase 2Results posted
• Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)CompletedNCT00790205Phase 3Results posted
• Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes MellitusCompletedNCT00789750Phase 3Results posted
• Welchol as Monotherapy for Type 2 Diabetes MellitusCompletedNCT00789737Phase 3Results posted
• Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 DiabetesCompletedNCT00789191Phase 3Results posted
• 12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic PatientsCompletedNCT00789035Phase 2Results posted
• Opportunistic Screening for Prediabetes and Early Diabetes in Primary CareCompletedNCT00787839Results posted
• Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 DiabetesCompletedNCT00786019Not applicableResults posted
• Response To Oral Agents in Diabetes (ROAD)- Pilot StudyCompletedNCT00780715Phase 4Results posted
• Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM PatientsCompletedNCT00778622Phase 4Results posted
• Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell MassCompletedNCT00775684Not applicableResults posted
• Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in DiabeticsCompletedNCT00773279Phase 3Results posted
• Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)TerminatedNCT00767000Phase 2Results posted
• Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes MellitusCompletedNCT00765817Phase 3Results posted
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of PioglitazoneCompletedNCT00763815Phase 3Results posted
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCompletedNCT00763451Phase 3Results posted
• A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active ComparatorCompletedNCT00760578Phase 2Results posted
• Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)CompletedNCT00758069Phase 2Results posted
• A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED)CompletedNCT00757601Phase 1Results posted
• Safety and Efficacy of Saxagliptin Plus Insulin With or Without MetforminCompletedNCT00757588Phase 3Results posted
• Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.CompletedNCT00755846Phase 2Results posted
• An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' TrialCompletedNCT00754624Phase 2Results posted
• MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).CompletedNCT00754130Phase 1Results posted
• Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With MetforminCompletedNCT00753896Phase 3Results posted
• Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic CrisesCompletedNCT00753142Not applicableResults posted
• Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive PatientsCompletedNCT00751114Phase 4Results posted
• BI 10773 add-on to Metformin in Patients With Type 2 DiabetesCompletedNCT00749190Phase 2Results posted
• Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate IntakeTerminatedNCT00747006Phase 2Results posted
• Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive PatientsCompletedNCT00744237Phase 4Results posted
• Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood GlucoseCompletedNCT00741390Not applicableResults posted
• A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is InappropriateCompletedNCT00740051Phase 3Results posted
• Diabetes Prevention and Control in the Workplace: A Pilot StudyCompletedNCT00739336Not applicableResults posted
• Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 DiabetesCompletedNCT00738023Phase 4Results posted
• Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic AdultsTerminatedNCT00737633Phase 2Results posted
• Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 DiabetesCompletedNCT00736879Phase 3Results posted
• Vitamin D, Insulin Resistance, and Cardiovascular DiseaseCompletedNCT00736632Not applicableResults posted
• Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DMCompletedNCT00736099Phase 3Results posted
• A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on MetforminCompletedNCT00734474Phase 2/3Results posted
• Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a ThiazolidinedioneCompletedNCT00729326Phase 4Results posted
• MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)CompletedNCT00722371Phase 3Results posted
• The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic PatientsCompletedNCT00716092Phase 2Results posted
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal InsulinCompletedNCT00715624Phase 3Results posted
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of SulfonylureaCompletedNCT00713830Phase 3Results posted
• GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCompletedNCT00712673Phase 3Results posted
• Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsCompletedNCT00707993Phase 3Results posted
• Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic PatientsCompletedNCT00707954Phase 1/2Results posted
• GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCompletedNCT00707031Phase 3Results posted
• Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)CompletedNCT00704132Phase 1Results posted
• A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)CompletedNCT00701090Phase 3Results posted
• Exercise Training and Glucose Metabolism in AgingCompletedNCT00701051Not applicableResults posted
• The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00700817Phase 3Results posted
• Supplements for Controlling Resistance to InsulinTerminatedNCT00699413Phase 4Results posted
• Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic ControlCompletedNCT00698932Phase 3Results posted
• A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and LiraglutideCompletedNCT00696657Phase 2Results posted
• Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 DiabetesCompletedNCT00692237Phase 4Results posted
• Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic SyndromeCompletedNCT00690755Results posted
• Efficacy of Lubiprostone in Combination With Standard PEG PreparationTerminatedNCT00689026Not applicableResults posted
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in MonotherapyCompletedNCT00688701Phase 3Results posted
• Insulin Glargine Versus Twice-Daily NPHTerminatedNCT00687453Phase 4Results posted
• Insulin Glargine at Bedtime or in AM Versus NPHCompletedNCT00686712Phase 4Results posted
• Sitagliptin in Combination With Metformin and SulfonylureaCompletedNCT00686634Phase 4Results posted
• Add-on to Thiazolidinedione (TZD) FailuresCompletedNCT00683878Phase 3Results posted
• Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR AloneCompletedNCT00683657Phase 3Results posted
• Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes PatientsCompletedNCT00680745Phase 3Results posted
• Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone HealthCompletedNCT00679939Phase 4Results posted
• Metformin Versus Insulin in Pregnant Women With Type 2 DiabetesCompletedNCT00678080Not applicableResults posted
• Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)CompletedNCT00676338Phase 3Results posted
• A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 DiabetesCompletedNCT00674986Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin MonotherapyCompletedNCT00674466Phase 2Results posted
• Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)CompletedNCT00673465Phase 1Results posted
• Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on InsulinCompletedNCT00673231Phase 3Results posted
• Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinCompletedNCT00669864Phase 4Results posted
• How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 DiabeticsCompletedNCT00667732Phase 4Results posted
• A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsCompletedNCT00666718Phase 3Results posted
• 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)CompletedNCT00666458Phase 3Results posted
• Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light BreakfastCompletedNCT00664534Phase 4Results posted
• Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal ImpairmentCompletedNCT00663260Phase 2/3Results posted
• Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 DiabetesCompletedNCT00661362Phase 3Results posted
• Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes PatientsCompletedNCT00660907Phase 3Results posted
• Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-RespondersCompletedNCT00660790Results posted
• A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes MellitusCompletedNCT00660309Phase 4Results posted
• Observational Study to Evaluate the Safety of Levemir® in DiabetesCompletedNCT00659295Results posted
• Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 DiabetesCompletedNCT00658021Phase 3Results posted
• Japanese P III vs Voglibose and PlaceboCompletedNCT00654381Phase 3Results posted
• Do Group Insulin Education Visits Reduce Barriers to Insulin Initiation?CompletedNCT00645528Not applicableResults posted
• An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release TabletsCompletedNCT00643851Phase 3Results posted
• Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary DiseaseTerminatedNCT00642616Phase 3Results posted
• An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 DiabetesCompletedNCT00642278Phase 2Results posted
• Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)CompletedNCT00641056Phase 3Results posted

← Diabetes Mellitus, Type 2 overview